MetaCap

Defiance Autism Impact ETF (ASD)

NASDAQ: ASDDefiance ETFs LLCHealthETFUSD

26.62+0.165 (+0.62%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

ASD chart

Full chart

Key facts

Holdings
10
Inception
Jun 1, 2026
Issuer
Defiance ETFs LLC
Index tracked
—
Category
Health
52-week range
24.59 – 28.52
Volume / Avg
450 / 350
Beta
—
Previous close
26.45

ASD ETF today

The Defiance Autism Impact ETF (ASD) is an exchange-traded fund from Defiance ETFs LLC in the Health category. It charges an expense ratio of 0.79%, or $79.00 per year on a $10,000 investment, and manages $1.3 million in assets. Its largest holding is Revvity Inc (RVTY) at 3.34% of assets, and the top 10 positions make up 28.7% of the portfolio out of 10 holdings.

ASD launched on Jun 1, 2026.

Summary generated from market data by MetaCap's automated system. Methodology

ASD top 10 holdings

ASD holdings by weight
#HoldingWeight
1RVTYRevvity Inc3.34%
2RGENRepligen Corp3.11%
3TEVA.TATeva Pharmaceutical Industries Ltd2.88%
4MCOV.B.STMedicover AB Class B2.82%
54506.TSumitomo Pharma Co Ltd2.79%
6LLYEli Lilly and Co2.77%
74578.TOtsuka Holdings Co Ltd2.76%
84502.TTakeda Pharmaceutical Co Ltd2.75%
9NOVN.SWNovartis AG Registered Shares2.73%
10PFEPfizer Inc2.72%

Top 10 holdings: 28.7% of assets.

ASD performance

1 week

+0.60%

ASD price return, excluding dividends.

ETFs similar to ASD

ASD ETF FAQ

What is the ASD price today?

ASD last traded at $26.62 as of Oct 9, 4:00 PM EDT, up 0.62% on the day.

What is ASD's expense ratio?

ASD has an expense ratio of 0.79%, which works out to about $79.00 per year for every $10,000 invested.

What are ASD's top holdings?

ASD's largest holdings are Revvity Inc (3.34%), Repligen Corp (3.11%), Teva Pharmaceutical Industries Ltd (2.88%), Medicover AB Class B (2.82%), Sumitomo Pharma Co Ltd (2.79%). The top 10 make up 28.7% of the fund.

How big is ASD?

ASD has about $1.3 million in assets under management spread across 10 holdings.

Explore